CARGO Therapeutics Statistics
Total Valuation
CRGX has a market cap or net worth of $208.39 million. The enterprise value is -$130.28 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRGX has 46.05 million shares outstanding. The number of shares has increased by 657.22% in one year.
| Current Share Class | 46.05M |
| Shares Outstanding | 46.05M |
| Shares Change (YoY) | +657.22% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 85.35% |
| Float | 31.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.79, with a Debt / Equity ratio of 0.08.
| Current Ratio | 13.79 |
| Quick Ratio | 13.65 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.76% and return on invested capital (ROIC) is -28.44%.
| Return on Equity (ROE) | -43.76% |
| Return on Assets (ROA) | -27.01% |
| Return on Invested Capital (ROIC) | -28.44% |
| Return on Capital Employed (ROCE) | -48.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.00M |
| Employee Count | 167 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -76.21% |
| 50-Day Moving Average | 4.06 |
| 200-Day Moving Average | 13.51 |
| Relative Strength Index (RSI) | 54.63 |
| Average Volume (20 Days) | 854,168 |
Short Selling Information
The latest short interest is 3.52 million, so 7.64% of the outstanding shares have been sold short.
| Short Interest | 3.52M |
| Short Previous Month | 3.55M |
| Short % of Shares Out | 7.64% |
| Short % of Float | 11.33% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -187.37M |
| Pretax Income | n/a |
| Net Income | -167.50M |
| EBITDA | -184.71M |
| EBIT | -187.37M |
| Earnings Per Share (EPS) | -$3.72 |
Full Income StatementBalance Sheet
The company has $339.70 million in cash and $29.43 million in debt, giving a net cash position of $338.67 million or $7.35 per share.
| Cash & Cash Equivalents | 339.70M |
| Total Debt | 29.43M |
| Net Cash | 338.67M |
| Net Cash Per Share | $7.35 |
| Equity (Book Value) | 360.23M |
| Book Value Per Share | 7.82 |
| Working Capital | 319.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$139.74 million and capital expenditures -$4.45 million, giving a free cash flow of -$144.19 million.
| Operating Cash Flow | -139.74M |
| Capital Expenditures | -4.45M |
| Free Cash Flow | -144.19M |
| FCF Per Share | -$3.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |